MARKETSACTIVE
41 mins ago
Medicenna Therapeutics Corp. (MDNA:CA) Discusses Updated MDNA11 Results From the Phase I II ABILITY-1 Study Transcript
SIGNALSMONITORMARKETS
What's happening
SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The first report grouped here was at 10 Nov 2026, 21:01 UTC. The headline in use is “Medicenna Therapeutics Corp. (MDNA:CA) Discusses Updated MDNA11 Results From the Phase I II ABILITY-1 Study Transcript”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Medicenna Therapeutics Corp. (MDNA:CA) Discusses Updated MDNA11 Results From the Phase I II ABILITY-1 Study Transcript
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Seeking Alpha
Reported by 1 outlet
- Seeking Alpha